Epigenetic regulation in vitiligo: mechanisms, challenges, and therapeutic opportunities

Area of Science:

• Dermatology and Genetics
• Molecular Biology and Epigenetics

Background:

• Vitiligo is a depigmenting skin disorder affecting millions worldwide due to epidermal melanocyte loss.
• Its pathogenesis involves complex interactions between genetic predisposition and environmental triggers.
• Epigenetic mechanisms are increasingly recognized as crucial contributors to vitiligo development.

Purpose of the Study:

• To review the role of epigenetic mechanisms in vitiligo pathogenesis.
• To explore specific epigenetic modifications including DNA methylation, histone modification, noncoding RNAs, chromatin remodeling, and 3D genome regulation.
• To discuss current challenges and future directions in vitiligo research and treatment.

Main Methods:

• Comprehensive literature review of studies investigating epigenetic factors in vitiligo.
• Analysis of molecular mechanisms linking epigenetic dysregulation to melanocyte destruction.
• Examination of genetic and environmental interactions influencing epigenetic modifications.

Main Results:

• DNA methylation dysregulation in genes like TYR and POMC disrupts melanocyte homeostasis.
• Histone modification imbalances, such as excessive histone deacetylase (HDAC) activation, promote melanocyte apoptosis.
• Noncoding RNAs (e.g., miR-211, lncRNAs), chromatin remodeling, and 3D genome regulation influence gene expression and immune responses in vitiligo.

Conclusions:

• Epigenetic mechanisms are central to vitiligo pathogenesis, driving melanocyte loss through various molecular pathways.
• Challenges in sample heterogeneity and model systems need addressing for further progress.
• Future research focusing on multiomics, organoid models, and epigenetic therapies (e.g., HDAC inhibitors, CRISPR-dCas9) holds significant promise for personalized vitiligo treatments.